BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2018
View Archived Issues
AhR antagonist PX-A24590 shows efficacy in pancreatic tumor model
Read More
Tavalisse becomes available in the U.S.
Read More
Xalkori receives FDA breakthrough therapy designation in two new indications
Read More
Clinical trial authorization received in U.K. to initiate phase I study with OLX-10010
Read More
Pivotal phase III of chidamide in combination with exemestane reaches primary endpoint
Read More
ITGA3 suggested as a therapeutic target in bladder cancer
Read More
European Commission grants authorization to Rubraca for recurrent ovarian cancer
Read More
FDA accepts NDA and grants priority review status for Firdapse
Read More
FDA accepts NDA for larotrectinib and grants priority review
Read More
U.S. researchers patent ITGA4 antagonists
Read More
Auckland Uniservices divulges CSF1R inhibitors
Read More
Russian investigators patent ciprofloxacin derivatives
Read More
New nicotinic alpha7 receptor PAMs presented by Merck & Co.
Read More
Genentech and Roche patent RORC ligands
Read More
EMA validates MAA for Inbrija
Read More
Galafold launched in Japan for Fabry disease
Read More
HyLeukin-7 begins U.S. trial in brain cancer
Read More
FDA accepts Cabometyx sNDA for previously treated HCC
Read More
miR-126 and miR-223 found as potential biomarkers of cardiac sarcoidosis
Read More
Antitumor efficacy seen with HERA-GITRL fusion protein from Apogenix
Read More
Nur77-deficient mice show altered dendritic cell functioning
Read More
FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause
Read More
Atox initiates phase II trial of reltecimod in acute kidney injury
Read More
FDA grants priority review to Sage's NDA for intravenous brexanolone for postpartum depression
Read More
DSMB clears phase II trial of AG-013 for oral mucositis to continue
Read More
